Ani Pharmaceuticals Inc. ANIP
Super Investor & Insider
1
Fondi che lo detengono
#1433
Rank consenso
1.4%
% dei portafogli
$492,852
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Polen Capital Management · Polen Capital Management | 0% | Buy | 6,409 | $492,852 |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
ANI Pharmaceuticals Inc. is a diversified biopharmaceutical company that develops, manufactures, and markets branded and generic prescription pharmaceuticals. It specializes in a range of dosage forms, including liquid, powder, oral solid-dose products, injectables, softgel capsules, semi-solids, topicals, and controll…
SectorHealthcare
ExchangeNASDAQ
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
Employees970
TickerANIP
Statistics
Market Cap$1.83B
Revenue (TTM)$883.4M
Net Income$78.3M
Net Margin8.9%
EPS$3.32
P/E20.88
P/S2.01
P/B3.10
EV/EBITDA10.33
ROE18.3%
Dividend Yield—
Price$79.97
Data: Twelve Data · Revenue = mcap / P/S